Paras Healthcare has raised about Rs 652.5 crore from a group of large institutional investors, one step before its initial public offering (IPO) opens for everyone else on October 21.
Notices posted on the stock exchanges’ websites show the company has allotted 94,15,584 equity shares to 39 funds. Each share was priced at Rs 693. Multiplying the number of shares by that price gives the total of roughly Rs 652.5 crore.
This kind of early fundraising is known as an anchor round. Before a public share sale begins, companies are allowed to offer a portion of the shares to a small circle of big, qualified institutions. These buyers commit to their purchase a day before the issue opens to ordinary investors. The aim is to show that professional money managers are willing to back the company at the proposed price.
For companies, a strong anchor book can help build confidence. Smaller investors often watch closely to see who has bought in and how much has been committed. A healthy list of participants can suggest that experienced investors have studied the business and found the valuation acceptable. However, it does not guarantee that the shares will rise after they begin trading, and individual buyers should still do their own research.
The 39 funds that took part were allotted shares at the top level of the price set for this round, which is Rs 693 per share. Once the public offer begins on October 21, retail buyers, wealthy individuals and other institutions will be able to place their bids.
Investors considering the issue should read the offer documents carefully. Important points include how the company plans to use the money, how its finances have performed, what risks it faces, and whether the asking price seems reasonable compared with similar firms in the healthcare sector.
The anchor allotment is only the first stage. The response from the wider market in the coming days will show how much appetite there really is for Paras Healthcare shares.